200mg Avigan administered to a French woman infected with Ebola virus

Fujifilm Corporation announced that the anti-influenza drug Avigan tablet 200mg (Favipiravir), developed by Toyama Chemical Co., Ltd, has been administered to a patient infected with the Ebola virus disease at a hospital in France.

The Japanese government has announced that they are ready to offer a drug developed by a Japanese company, as a potential treatment for Ebola.

Avigan was provided as an emergency measure upon consultations with the Japanese government, in response to the request by French government agency, French National Agency for Medicines and Health Products Safety (ANSM), to Fujifilm asking for the drug as a means of treatment of a French nurse infected with the Ebola virus.

The French nurse was diagnosed as Ebola virus disease while engaging in healthcare work in Monrovia, Liberia's capital, and was repatriated to France for treatment. ANSM stated that a treatment combining Avigan and another experimental has started on September 19. The patient is taking Avigan as of September 25.

Fujifilm and Toyama Chemical will continue to work together with relevant pharmaceutical authorities, international organizations and infectious disease specialists to explore the potential of leveraging Avigan for patients with the Ebola virus disease.

Provided by Fujifilm
Citation: 200mg Avigan administered to a French woman infected with Ebola virus (2014, September 26) retrieved 28 March 2024 from https://medicalxpress.com/news/2014-09-200mg-avigan-french-woman-infected.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Japan ready to offer flu drug for Ebola treatment (Update)

 shares

Feedback to editors